GU Cancers 2020 | Individualizing RCC treatment
VJOncology is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Martin Voss, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses updates on the progression towards individualizing therapy for metastatic renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.
Get great new content delivered to your inboxSign up